BeOne Medicines Ltd. (ONC) stock
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/302571% above fair value
$413.26+1.97 (+0.48%)
Close on Nov 17, 2026Market cap $46.99BP/E 73.9Yield –
BeOne Medicines pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
BeOne Medicines's pe ratio was 75.1× on Nov 11, 2026, against 873.4× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 75.1× | −703.9 |
| 2025 | Dec 31, 2025 | 779.0× | – |
See a number that looks wrong?